FDA Inspection
Zhejiang Huahai PharmaceuticalZhejiang Huahai Pharmaceutical – FDA Inspection, Aug 3, 2018
Record Details
This FDA Inspection record concerns Zhejiang Huahai Pharmaceutical, with an inspection on August 3, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 18f98fae-eaca-4740-bb4c-d005f04e2a6b
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1062283
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Zhejiang Huahai Pharmaceutical
5| Date | Classification | Office | Project area |
|---|---|---|---|
| November 20, 2024 | Not classified | Office of Inspections and Investigations | |
| July 29, 2021 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 19, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 23, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 8, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Zhejiang Huahai Pharmaceutical
- FDA Inspection 1255905 - 2024-11-20
- FDA Inspection 1150702 - 2021-07-29
- FDA Inspection 1012805 - 2017-05-19
- FDA Inspection 886530 - 2014-05-23
- FDA Inspection 712157 - 2010-09-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.